These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 17150286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity.
    Pittman PR, Fisher D, Quinn X, Schmader T, Barrera-Oro JG.
    Vaccine; 2013 Oct 17; 31(44):5009-14. PubMed ID: 24026013
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.
    Pittman PR, Norris SL, Barrera Oro JG, Bedwell D, Cannon TL, McKee KT.
    Vaccine; 2006 Apr 24; 24(17):3654-60. PubMed ID: 16497418
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
    Parreiras PM, Sirota LA, Wagner LD, Menzies SL, Arciniega JL.
    Vaccine; 2009 Jul 16; 27(33):4537-42. PubMed ID: 19501205
    [Abstract] [Full Text] [Related]

  • 15. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.
    Quinn CP, Dull PM, Semenova V, Li H, Crotty S, Taylor TH, Steward-Clark E, Stamey KL, Schmidt DS, Stinson KW, Freeman AE, Elie CM, Martin SK, Greene C, Aubert RD, Glidewell J, Perkins BA, Ahmed R, Stephens DS.
    J Infect Dis; 2004 Oct 01; 190(7):1228-36. PubMed ID: 15346332
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women.
    Zhang Y, Martin SW, Rose CE, Biagini RE, Franzke LH, Smith JP, Sammons DL, Robertson SA, McNeil MM.
    Pharmacoepidemiol Drug Saf; 2008 Nov 01; 17(11):1060-7. PubMed ID: 18781705
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques.
    Livingston BD, Little SF, Luxembourg A, Ellefsen B, Hannaman D.
    Vaccine; 2010 Jan 22; 28(4):1056-61. PubMed ID: 19896452
    [Abstract] [Full Text] [Related]

  • 19. Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.
    Semenova VA, Steward-Clark E, Stamey KL, Taylor TH, Schmidt DS, Martin SK, Marano N, Quinn CP.
    Clin Diagn Lab Immunol; 2004 Sep 22; 11(5):919-23. PubMed ID: 15358653
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
    Sloat BR, Cui Z.
    J Pharm Pharmacol; 2006 Apr 22; 58(4):439-47. PubMed ID: 16597361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.